URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A9

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 22:47:52 GMT 2025` Edited by `admin` on `Mon Mar 31 22:47:52 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	3318TFY23Q
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

UDP-GLUCURONOSYLTRANSFERASE 1-9

Preferred Name

English

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A9

Common Name

English

UDP-GLUCURONOSYLTRANSFERASE 1A9

Common Name

English

UGT1A9

Common Name

English

UGT-1A9

Common Name

English

Code System Code Type Description

FDA UNII

3318TFY23Q

Created by admin on Mon Mar 31 22:47:53 GMT 2025 , Edited by admin on Mon Mar 31 22:47:53 GMT 2025

PRIMARY

WIKIPEDIA

UGT1A9

Created by admin on Mon Mar 31 22:47:53 GMT 2025 , Edited by admin on Mon Mar 31 22:47:53 GMT 2025

PRIMARY

CAS

400706-57-2

Created by admin on Mon Mar 31 22:47:53 GMT 2025 , Edited by admin on Mon Mar 31 22:47:53 GMT 2025

PRIMARY

UNIPROT

O60656

Created by admin on Mon Mar 31 22:47:53 GMT 2025 , Edited by admin on Mon Mar 31 22:47:53 GMT 2025

PRIMARY

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_46
N	1_267
N	1_319

Related Record Type Details


					RE0V0T1ES0

Resmetirom

INHIBITOR -> METABOLIC ENZYME

Comments:

clinical relevance of inhibition is unknown

Amount:


					66974FR9Q1

CHLORAMPHENICOL

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MINOR


					V8G4MOF2V9

DEFERASIROX

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MINOR


					6S49DGR869

CANAGLIFLOZIN ANHYDROUS

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR


					NM2KXJ990T

NEBICAPONE

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR


					YI7VU623SF

PROPOFOL

SUBSTRATE -> METABOLIC ENZYME


					58IFB293JI

VORINOSTAT

SUBSTRATE -> METABOLIC ENZYME

Amount:


					19P708E787

SARPOGRELATE

SUBSTRATE -> METABOLIC ENZYME


					N62TGJ04A1

ESAXERENONE

SUBSTRATE -> METABOLIC ENZYME


					K673DMO5H9

GLASDEGIB

SUBSTRATE -> METABOLIC ENZYME

Comments:

Glasdegib is metabolized primarily by the CYP3A4 pathway, with minor contributions by CYP2C8 and UGT1A9

Interaction Type:

MINOR


					7J8897W37S

DRONABINOL

SUBSTRATE -> METABOLIC ENZYME

Amount:


					7LXU5N7ZO5

FUROSEMIDE

SUBSTRATE -> METABOLIC ENZYME

Amount:


					X05U0N2RCO

DAROLUTAMIDE

SUBSTRATE -> METABOLIC ENZYME


					HMH0132Z1Q

CABOTEGRAVIR

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MINOR

Amount:


					TUPWG40JAL

MORPONIDAZOLE

SUBSTRATE -> METABOLIC ENZYME


					24T2A1DOYB

REGORAFENIB ANHYDROUS

SUBSTRATE -> METABOLIC ENZYME


					8FG9H9D31J

TAFAMIDIS

SUBSTRATE -> METABOLIC ENZYME

Amount:


					5I5Y2789ZF

VILOXAZINE

SUBSTRATE -> METABOLIC ENZYME

Amount:


					DKO1W9H7M1

DOLUTEGRAVIR

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MINOR


					2BTY8KH53L

DEFERIPRONE

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MINOR


					0ES1C2KQ94

SELICICLIB

SUBSTRATE -> METABOLIC ENZYME

Amount:


					UC7ILE15NN

2,3,7-TRICHLORODIBENZO-P-DIOXIN

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR


					B9CTI9GB8F

TRIHYDROXYCHALCONE

SUBSTRATE -> METABOLIC ENZYME


					X0457TK6C8

EBRACTEOLATA COMPOUND B

SUBSTRATE -> METABOLIC ENZYME


					VD2YSN1AFD

OLODATEROL

SUBSTRATE -> METABOLIC ENZYME


					62XCK0G93T

ORNIDAZOLE

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR


					S798V6YJRP

EDARAVONE

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

IN-VITRO

Qualification:

Amount:


					19GBJ60SN5

CANNABIDIOL

SUBSTRATE -> METABOLIC ENZYME

Amount:


					SQ8A3S5101

FOSTAMATINIB

SUBSTRATE -> METABOLIC ENZYME


					637E494O0Z

LORCASERIN

SUBSTRATE -> METABOLIC ENZYME

Amount:


					LV66ADM269

Vericiguat

SUBSTRATE -> METABOLIC ENZYME

Amount:


					834YJF89WO

Belumosudil

INHIBITOR -> METABOLIC ENZYME

Comments:

Inhibits at clinically relevant concentrations.

Amount:


					101V0R1N2E

Febuxostat

SUBSTRATE -> METABOLIC ENZYME


					22VKV8053U

Raltegravir

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MINOR


					516DO4KL5R

CP-544439

SUBSTRATE -> METABOLIC ENZYME


					3T1SS4E7AG

ENASIDENIB

SUBSTRATE -> METABOLIC ENZYME


					9647FM7Y3Z

PANOBINOSTAT

SUBSTRATE -> METABOLIC ENZYME

Comments:

IN VITRO

Amount:


					337G83N988

LASOFOXIFENE

SUBSTRATE -> METABOLIC ENZYME


					PFP09575EX

UAB-30

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR


					HDC1R2M35U

Empagliflozin

SUBSTRATE -> METABOLIC ENZYME


					Z5MR2Y1IJJ

ENAVOGLIFLOZIN

SUBSTRATE -> METABOLIC ENZYME

Amount:


					P5T6BYS22Y

LICOFELONE

SUBSTRATE -> METABOLIC ENZYME


					BGG1Y1ED0Y

TRICLOCARBAN

SUBSTRATE -> METABOLIC ENZYME

Interaction Type:

MAJOR

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID REPLACEMENT	[1_74]		LYSINE	Amount:	N6-SUCCINYLLYSINE	3LH35AJA5L

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED)	CHEMICAL